Support Services

The traditional paradigm of tumor profiling for single gene mutation in cancer involves multiple tests, each targeting a single gene and revealing only a portion of what is happening within the tumor, and can lead to a “one size fits all” view of possible therapies. This is effective in some cases but can lead to increased cost and a longer time to get the answer. This strategy is successful when it leads to innovation and improves the standard of care, but fails when it becomes trial and error.
 

Time has come, when there is need of complete paradigm shift for comprehensive cancer care, by adopting 'Next Generation Sequencing Technologies' to add a differentiation in cancer classification and patient stratification, to understand each individual patient's response to targeted therapies. This will enable physicians to go beyond the one-size-fits-all model of medicine, to make the most effective clinical decisions for each patient.